In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1478-6362
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response ; volume:21 ; number:1 ; day:18 ; month:1 ; year:2019 ; pages:1-8 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (18.1.2019), 1-8, 12.2019

Urheber
Moel, Emma C. de
Derksen, Veerle F. A. M.
Trouw, Leendert A.
Bang, Holger
Collée, Gerard
Lard, Leroy R.
Ramiro, Sofia
Huizinga, Tom W. J.
Allaart, Cornelia F.
Toes, René E. M.
Woude, Diane van der
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13075-019-1815-0
URN
urn:nbn:de:101:1-2019022022580727514101
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:51 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Moel, Emma C. de
  • Derksen, Veerle F. A. M.
  • Trouw, Leendert A.
  • Bang, Holger
  • Collée, Gerard
  • Lard, Leroy R.
  • Ramiro, Sofia
  • Huizinga, Tom W. J.
  • Allaart, Cornelia F.
  • Toes, René E. M.
  • Woude, Diane van der
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity

Immunosuppression

Immunosuppression

Chemical immunosuppression

Chemical immunosuppression

Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis

Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity

Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab

The flow limit of reflect-reflect-relax

zweidimensionales bewegtes Bild

The flow limit of reflect-reflect-relax

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis

Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

Verbundene Objekte